Follow The Filings

GEHC GE HealthCare

Health Care, filed as GE HEALTHCARE TECHNOLOGIES I (COMMON STOCK), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 5 managers in 2026 Q2, sold by 5

  • 1 Owner
  • #117
  • Max 0.0%
  • Master 0.22%
  • $24K

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Kentucky Trust Co., Kentucky Trust). Not free-float ownership.

  1. Kentucky Trust Co. 0.01%

Who owns GEHC

Sorted by value, long equity only, as of 2026 Q3.

History
Kentucky Trust Co., Kentucky Trust 0.01% Hold 364 $24K History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by GEHC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All GEHC insider trades
  • $6.4M bought by 8 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Kevin Lobo Director
    Buy
    $642K 10,000 shares at $64.18 +229% to stake
    Traded May 22 Filed May 26
  2. Rodney F Hochman Director
    Buy
    $100K 1,618 shares at $62.03 New stake
    Traded May 12 Filed May 13
  3. Watkin Phoebe L. Yang Director
    Buy
    $63K 1,000 shares at $63.01 +7.9% to stake
    Traded May 8 Filed May 11
  4. William J Stromberg Director
    Buy
    $62K 1,000 shares at $61.69 +7% to stake
    Traded May 6 Filed May 7
  5. H Lawrence Culp Jr. Director
    Buy
    $5M 80,805 shares at $61.88 +115% to stake
    Traded May 6 Filed May 7
  6. James Saccaro CFO
    Buy
    $201K 3,310 shares at $60.60 +3.9% to stake
    Traded May 1 Filed May 1
  7. Frank R Jimenez GC & Corporate Secretary
    Buy
    $106K 1,750 shares at $60.45 +1.9% to stake
    Traded Apr 30 Filed Apr 30
  8. Peter J Arduini CEO
    Buy
    $250K 4,169 shares at $59.93 +1.6% to stake
    Traded Apr 30 Filed Apr 30

Also filed in the last 12 months, not counted as buying or selling: 37 share withholdings for taxes and 32 stock grants.

Congress

5 members of Congress traded GEHC in the last three years: 3 buys and 4 sales. 11 members listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  2. Terri A. Sewell D-AL-7 Sell $1K–$15K Mar 25 filed Apr 21
  3. Warren Davidson R-OH-8 Sell $1K–$15K Mar 23 filed Mar 25
  4. Austin Scott R-GA-8Spouse Sell $1K–$15K Mar 27, 2025 filed Aug 13, 2025
  5. Robert P. Bresnahan, Jr. R-PA-8 Buy $1K–$15K May 15, 2025 filed May 31, 2025
  6. Robert P. Bresnahan, Jr. R-PA-8 Sell $1K–$15K Apr 8, 2025 filed Apr 28, 2025

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
10-Q
8-K 2.02,5.02,9.01
8-K 5.02,7.01,9.01
8-K 5.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 7.01,9.01
8-K 2.02,5.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 5.07,8.01

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $19.55B $19.67B $20.62B
Gross profit $7.92B $8.2B $8.25B
Gross margin * 40.5% 41.7% 40.0%
Net income $1.57B $1.99B $2.08B
Net margin * 8.0% 10.1% 10.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $9.41B $9.9B $12.5B
Total non-current assets * $23.04B $23.19B $24.4B
Total assets $32.45B $33.09B $36.91B
Total current liabilities $8.98B $9.55B $9.1B
Total non-current liabilities * $16.16B $14.88B $17.2B
Total equity $7.13B $8.45B $10.38B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from investing -$0.558B -$0.914B -$1.05B
Cash from financing -$478M -$573M $617M
Net change in cash $1.06B $0.387B $1.62B

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.